IQGAP1 and acute myeloid leukemia: Genetic perturbation (knockdown) validated dependency of AML on IQGAP1 manifested by reduced survival and colony formation (Fig. 2D) providing the proof of concept that IQGAP1 may be a therapeutic target in AML.